Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hangkai Huang

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|May 6, 2022
Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver DiseaseHangkai Huang, Yanjun Guo, Zhening Liu, et al.
Digestive Diseases and Sciences|December 13, 2022
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean AdultsShuxia Shen, Hangkai Huang, Jinghua Wang, et al.
Journal of Diabetes Investigation|December 18, 2023
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populationsHangkai Huang, Jiarong Xie, Linxiao Hou, et al.
Journal of Clinical Gastroenterology|February 13, 2024
Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver DiseaseHangkai Huang, Zhening Liu, Yanjun Guo, et al.
Diabetology & Metabolic Syndrome|November 21, 2023
Remnant cholesterol and severity of nonalcoholic fatty liver diseaseHangkai Huang, Jinghua Wang, Li Wu, et al.
Mediators of Inflammation|December 17, 2021
Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional StudyHangkai Huang, Qinqiu Wang, Xiaoying Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2023
Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver DiseaseHangkai Huang, Jiarong Xie, Yan Zeng, et al.
Hepatology (Baltimore, Md.)|August 16, 2022
The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization studyJiarong Xie, Hangkai Huang, Zhening Liu, et al.
Hepatology International|June 15, 2023
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort studyJiarong Xie, Lei Xu, Hangkai Huang, et al.
Metabolism: Clinical and Experimental|August 23, 2023
Olfactomedin 4 deletion exacerbates nonalcoholic fatty liver disease through P62-dependent mitophagy in miceShenghui Chen, Xinyu Wang, Zhening Liu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|May 6, 2022
Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver DiseaseHangkai Huang, Yanjun Guo, Zhening Liu, et al.
Digestive Diseases and Sciences|December 13, 2022
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean AdultsShuxia Shen, Hangkai Huang, Jinghua Wang, et al.
Journal of Diabetes Investigation|December 18, 2023
Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in nonobese populationsHangkai Huang, Jiarong Xie, Linxiao Hou, et al.
Journal of Clinical Gastroenterology|February 13, 2024
Long-term Use of Proton Pump Inhibitors is Associated With An Increased Risk of Nonalcoholic Fatty Liver DiseaseHangkai Huang, Zhening Liu, Yanjun Guo, et al.
Diabetology & Metabolic Syndrome|November 21, 2023
Remnant cholesterol and severity of nonalcoholic fatty liver diseaseHangkai Huang, Jinghua Wang, Li Wu, et al.
Mediators of Inflammation|December 17, 2021
Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional StudyHangkai Huang, Qinqiu Wang, Xiaoying Shi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2023
Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver DiseaseHangkai Huang, Jiarong Xie, Yan Zeng, et al.
Hepatology (Baltimore, Md.)|August 16, 2022
The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization studyJiarong Xie, Hangkai Huang, Zhening Liu, et al.
Hepatology International|June 15, 2023
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort studyJiarong Xie, Lei Xu, Hangkai Huang, et al.
Metabolism: Clinical and Experimental|August 23, 2023
Olfactomedin 4 deletion exacerbates nonalcoholic fatty liver disease through P62-dependent mitophagy in miceShenghui Chen, Xinyu Wang, Zhening Liu, et al.
Pageof 4